Delivery Order SPE2DB22D9316-SPE2DB24FYP52

Award Date 6/24/24
Potential Completion Date 6/25/24
Potential Value $33K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D9316
    Indefinite Delivery Contract
  • SPE2DB22D9316-SPE2DB24FYP52
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $32,873.49 contract is for the delivery of 120-count capsules of the prescription drug Xtandi 40 mg.

This delivery order contract is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group holds multiple prime vendor contracts with the Department of Defense and Department of Veterans Affairs to distribute a variety of branded and generic medications, biologics, and medical consumables. This specific delivery order does not have a set-aside designation.

Generated 9/23/24, 9:49 AM